Moffitt Medical GroupSenior Adult Oncology Program 12902 Usf Magnolia Dr, Tampa, FL 33612 (813)7456769 (phone), (813)7453730 (fax)
Education:
Medical School New York University School of Medicine Graduated: 1980
Procedures:
Chemotherapy
Conditions:
Melanoma Rectal, Abdomen, Small Intestines, or Colon Cancer Abdominal Hernia Acute Pancreatitis Acute Renal Failure
Languages:
English Spanish
Description:
Dr. Weber graduated from the New York University School of Medicine in 1980. He works in Tampa, FL and specializes in Medical Oncology. Dr. Weber is affiliated with Moffitt Cancer Center.
Dr. Weber graduated from the Pennsylvania State University College of Medicine in 1993. He works in Ephrata, PA and specializes in Family Medicine. Dr. Weber is affiliated with WellSpan Ephrata Community Hospital.
Mr. Weber works in Raleigh, NC and 1 other location and specializes in Pain Management. Mr. Weber is affiliated with Duke Raleigh Hospital and Wakemed Raleigh Campus.
University of Louisville - Electrical Engineering, Atherton High School
About:
I now own my own company Frozen Mercury Productions, I hope it's the start of something amazing. I am a jack of all trades I know something about everything, and am willing to share all my knowled...
Tagline:
Jeffrey Arra Weber
Jeffrey Weber
Work:
Booz Allen Hamilton
Education:
Virginia Polytechnic Institute and State University
For covid-19 patients, cytokine storms are a major reason that some require intensive care and ventilation, said Jeffrey Weber, deputy director of the Perlmutter Cancer Center at NYU Langone Medical Center.
Date: Apr 15, 2020
Category: More news
Source: Google
New clinical trial might change the standard treatment for melanoma
Results like this will change how we practice medicine, said Jeffrey Weber, a professor of medicine at NYU Langone School of Medicine, who presented the findings at the annual meeting of the European Society for Medical Oncology in Madrid. The results were published simultaneously online in the Ne
"This is clearly an outstanding science result that sets the scene for the further development of the test to quantify [immune biomarkers] in different malignancies," said Dr. Jeffrey Weber, an immunologist and oncologist at the Moffitt Cancer Center in Tampa, Fla., who was
"It's the first in a series of targeted drugs, meaning it's a drug that targets a specific mutation in about half of all melanomas that begin on the skin," said Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at the H. Lee Moffitt Cancer Center. "It's really imp
Date: Aug 21, 2011
Category: Health
Source: Google
New melanoma drug had trial run at Moffitt Cancer Center
Dr. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt, was an investigator on a Phase II student that enrolled 132 patients. The study showed that vemurafenib (pronounced vem-yoo-RAF-en-ib) shrank tumors in 52 percent of trial participants, and participa